BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 33659220)

  • 1. Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to
    Nardelli C; Gentile I; Setaro M; Di Domenico C; Pinchera B; Buonomo AR; Zappulo E; Scotto R; Scaglione GL; Castaldo G; Capoluongo E
    Front Cell Infect Microbiol; 2021; 11():625581. PubMed ID: 33659220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.
    Mostafa HH; Fissel JA; Fanelli B; Bergman Y; Gniazdowski V; Dadlani M; Carroll KC; Colwell RR; Simner PJ
    mBio; 2020 Nov; 11(6):. PubMed ID: 33219095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection and viral load are associated with the upper respiratory tract microbiome.
    Rosas-Salazar C; Kimura KS; Shilts MH; Strickland BA; Freeman MH; Wessinger BC; Gupta V; Brown HM; Rajagopala SV; Turner JH; Das SR
    J Allergy Clin Immunol; 2021 Apr; 147(4):1226-1233.e2. PubMed ID: 33577896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019.
    Wang K; Zhang X; Sun J; Ye J; Wang F; Hua J; Zhang H; Shi T; Li Q; Wu X
    Chest; 2020 Nov; 158(5):1876-1884. PubMed ID: 32569635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metagenomic next-generation sequencing of nasopharyngeal microbiota in COVID-19 patients with different disease severities.
    Aljabr W; Dandachi I; Abbas B; Karkashan A; Al-Amari A; AlShahrani D
    Microbiol Spectr; 2024 May; 12(5):e0416623. PubMed ID: 38557102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NGS analysis of nasopharyngeal microbiota in SARS-CoV-2 positive patients during the first year of the pandemic in the Campania Region of Italy.
    Giugliano R; Sellitto A; Ferravante C; Rocco T; D'Agostino Y; Alexandrova E; Lamberti J; Palumbo D; Galdiero M; Vaccaro E; Pagliano P; Weisz A; Giurato G; Franci G; Rizzo F
    Microb Pathog; 2022 Apr; 165():105506. PubMed ID: 35358660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 16S rRNA gene sequencing of rectal swab in patients affected by COVID-19.
    Mazzarelli A; Giancola ML; Farina A; Marchioni L; Rueca M; Gruber CEM; Bartolini B; Ascoli Bartoli T; Maffongelli G; Capobianchi MR; Ippolito G; Di Caro A; Nicastri E; Pazienza V;
    PLoS One; 2021; 16(2):e0247041. PubMed ID: 33596245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal Pathology in Samples From Coronavirus Disease 2019 (COVID-19)-Positive Patients.
    Westerhoff M; Jones D; Hrycaj SM; Chan MP; Pantanowitz L; Tu H; Choi K; Greenson J; Lamps L
    Arch Pathol Lab Med; 2021 Sep; 145(9):1062-1068. PubMed ID: 33961007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
    Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
    Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
    Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity.
    Kim JG; Zhang A; Rauseo AM; Goss CW; Mudd PA; O'Halloran JA; Wang L
    J Med Virol; 2023 Feb; 95(2):e28445. PubMed ID: 36583481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of viral load in different specimen types and serum antibody levels of COVID-19 patients.
    Li L; Tan C; Zeng J; Luo C; Hu S; Peng Y; Li W; Xie Z; Ling Y; Zhang X; Deng E; Xu H; Wang J; Xie Y; Zhou Y; Zhang W; Guo Y; Liu Z
    J Transl Med; 2021 Jan; 19(1):30. PubMed ID: 33413461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COVID-19 Lockdown on the Nasopharyngeal Microbiota of Children and Adults Self-Confined at Home.
    Rocafort M; Henares D; Brotons P; Launes C; Fernandez de Sevilla M; Fumado V; Barrabeig I; Arias S; Redin A; Ponomarenko J; Mele M; Millat-Martinez P; Claverol J; Balanza N; Mira A; Garcia-Garcia JJ; Bassat Q; Jordan I; Muñoz-Almagro C
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface and Air Contamination With Severe Acute Respiratory Syndrome Coronavirus 2 From Hospitalized Coronavirus Disease 2019 Patients in Toronto, Canada, March-May 2020.
    Kotwa JD; Jamal AJ; Mbareche H; Yip L; Aftanas P; Barati S; Bell NG; Bryce E; Coomes E; Crowl G; Duchaine C; Faheem A; Farooqi L; Hiebert R; Katz K; Khan S; Kozak R; Li AX; Mistry HP; Mozafarihashjin M; Nasir JA; Nirmalarajah K; Panousis EM; Paterson A; Plenderleith S; Powis J; Prost K; Schryer R; Taylor M; Veillette M; Wong T; Zoe Zhong X; McArthur AG; McGeer AJ; Mubareka S
    J Infect Dis; 2022 Mar; 225(5):768-776. PubMed ID: 34850051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Potential Transmission of SARS-CoV-2 from Patients with Negative RT-PCR Swab Tests to Others: Two Related Clusters of COVID-19 Outbreak.
    Cao G; Tang S; Yang D; Shi W; Wang X; Wang H; Li C; Wei J; Ma L
    Jpn J Infect Dis; 2020 Nov; 73(6):399-403. PubMed ID: 32475877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Super Dominant Pathobiontic Bacteria in the Nasopharyngeal Microbiota Cause Secondary Bacterial Infection in COVID-19 Patients.
    Qin T; Wang Y; Deng J; Xu B; Zhu X; Wang J; Zhou H; Zhao N; Jin F; Ren H; Wang H; Li Q; Xu X; Guo Y; Li R; Xiong Y; Wang X; Guo J; Zheng H; Hou X; Wan K; Zhang J; Lu J; Kan B; Xu J
    Microbiol Spectr; 2022 Jun; 10(3):e0195621. PubMed ID: 35579467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Infection is Associated with Age- and Gender-Specific Changes in the Nasopharyngeal Microbiome.
    Bozza S; Nunzi E; Frias-Mazuecos A; Pieraccini G; Pariano M; Renga G; Mencacci A; Talesa VN; Antognelli C; Puccetti P; Romani L; Costantini C
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):59. PubMed ID: 38420819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity.
    Gauthier NPG; Locher K; MacDonald C; Chorlton SD; Charles M; Manges AR
    PLoS One; 2022; 17(10):e0275815. PubMed ID: 36240246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Four Molecular
    Zhen W; Manji R; Smith E; Berry GJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32341143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.